LATEST TRIALS

  • Solide Tumores
    SECAR I - Part I: A study of MTD of Sodium selenite in patients with advanced carcinoma. A phase I study
  • Solide Tumores
    MASTIFF MTH1, A phase I, Study on Tumors Inhibition, First in human, First in class
  • Lung Cancer
    DurSab - Stereotactic Ablative Body Radiotherapy (SABR) followed by Durvalumab as maintenance treatment in patients with advanced non-small cell lung cancer not progressing after 4 to 6 cycles of first-line conventional chemotherapy

NORDIC COOPERATION

Norway Norway Sweden Finland Finland Finland Aarhus Herlev Copenhagen Copenhagen Lund